Essential Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Essential Partners's HALO Position: Q3 2026 in Review
Essential Partners held its Halozyme (HALO) position steady in Q3 2026 at 30 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1706.
Essential Partners first reported a position in HALO in Q2 2025 and has held it in 6 quarters since. The position peaked at $67.1K in Q3 2025. 161 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Essential Partners held 30 shares of Halozyme worth $3.31K as of Q3 2026.
- Essential Partners left its Halozyme share count unchanged in Q3 2026.
- Halozyme made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1706 holding.
- Essential Partners first reported a position in Halozyme in Q2 2025 and has held it in 6 quarters since.
- Essential Partners's Halozyme position peaked at $67.1K in Q3 2025.
- 161 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.